| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |